Patents by Inventor Mengjie Shen

Mengjie Shen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8846671
    Abstract: The heterocyclic alkynyl benzene compounds of formula (I), their pharmaceutically acceptable salts and stereoisomers thereof, as well as application in preparing drugs for preventing or treating tumors. The compounds can overcome the clinically induced resistance against Gleevec.
    Type: Grant
    Filed: June 3, 2011
    Date of Patent: September 30, 2014
    Assignee: Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences
    Inventors: Ke Ding, Deping Wang, Duanqing Pei, Zhang Zhang, Mengjie Shen, Kun Luo, Yubing Feng
  • Publication number: 20130196985
    Abstract: The heterocyclic alkynyl benzene compounds of formula (I), their pharmaceutically acceptable salts and stereoisomers thereof, as well as application in preparing drugs for preventing or treating tumors. The compounds can overcome the clinically induced resistance against Gleevec.
    Type: Application
    Filed: June 3, 2011
    Publication date: August 1, 2013
    Applicant: Guangzzhou Institute of Biomedicine and Health, Chineses Academy of Sciences
    Inventors: Ke Ding, Deping Wang, Duanqing Pei, Zhang Zhang, Mengjie Shen, Kun Luo, Yubing Feng
  • Patent number: D1029036
    Type: Grant
    Filed: September 5, 2022
    Date of Patent: May 28, 2024
    Assignee: Keeson Technology Corporation Limited
    Inventors: Huafeng Shan, Xiaodong Shou, Yifan Ma, Qi Shen, Jijia Liu, Mengjie Su, Lingfeng Yu, Xintao Shen, Wenchao Jin